Wilmington, Delaware, United States, Transparency Market Research Inc. – The global liposome drug delivery market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a considerable CAGR from 2019 to 2027.
Wilmington, Delaware, United States, Transparency Market Research Inc. – The global liposome drug delivery market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a considerable CAGR from 2019 to 2027. Liposomes are considered the novel drug delivery systems, which are defined as vesicular structures consisting of bilayers formed spontaneously when phospholipids are dispersed in water. Liposomes aid in delivering drugs by the process of diffusion rather than by direct cell fusion.
The global liposome drug delivery market is driven by rise in prevalence of cancer, which is primarily treated with liposome encapsulated drugs, increase in applications of liposomes as drug delivery systems, its advantages, technological advances, and strong pipeline of drugs.
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28571
Advantages offered by liposome drug delivery, including the unique ability to entrap both hydrophilic and lipophilic compounds and enabling a diverse range of drugs to be encapsulated by these vesicles, contribute to the growth of the global market.
Applications of liposomes in drug delivery can be segregated into diagnostic and therapeutic. These applications include anti-fungal, anti-cancer, and anti-inflammatory drugs, in addition to therapeutic gene delivery. Major drugs formulated by employing liposome drug delivery include Doxil, AmBisome, and DepoDur. Surge in applications of liposomes as drug delivery systems contributes to the growth of the global liposome drug delivery market.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=28571
Liposome Drug Delivery Market: Segmentation
The global liposome drug delivery market has been segmented based on product, technology, application, and region
In terms of product, the global liposome drug delivery market has been categorized into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others
Based on technology, the global liposome drug delivery market has been classified into stealth liposome technology, non-PEGylated liposome technology, and DepoFoam liposome technology
In terms of application, the global liposome drug delivery market has been divided into fungal diseases, cancer therapy, viral vaccines, pain management, and photodynamic therapy. The cancer therapy segment dominated the market in 2018 and the trend is anticipated to continue during the forecast period. This can be attributed to rise in prevalence of cancer and strong pipeline of drugs focused on offering treatment for various types of cancer.
Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=28571
Liposome Drug Delivery Market: Regional Segmentation
In terms of region, the global liposome drug delivery market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America dominated the global liposome drug delivery market in 2018 and the trend is expected to continue during the forecast period
The liposome drug delivery market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. Growth of the market in the region can be attributed to increase in number of patients suffering from chronic diseases and focus of leading players on strengthening presence in emerging markets.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=28571
Liposome Drug Delivery Market: Major Players
Key players operating in the global liposome drug delivery market are
- Spectrum Pharmaceuticals, Inc.
- Astellas Pharma, Inc.
- Gilead Sciences, Inc.
- Celsion Corporation
- Ipsen Pharma
- Pacira BioSciences, Inc.
- Luye Pharma Group
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Johnson & Johnson
These players focus on adopting inorganic growth strategies and product launches to strengthen their product portfolio. These players also emphasize on enhancement of technological platforms for the development of liposome drugs. For instance, Celsion Corporation focuses on the development of cancer therapies based on its Lysolipid Thermally Sensitive Liposomes (LTSL), which is a heat-sensitive liposomal formulation. The other technology platforms include TheraPlas, a non-viral delivery system for therapeutic plasmids. The third technology platform is TheraSilence, which aids in delivering synthetically generated inhibitory RNA (RNAi) to regulate protein expression in target cells.
More Trending Reports by Transparency Market Research –
TNF Inhibitors Market: The global TNF inhibitors market is relatively competitive, with many prominent competitors. In terms of market share, a few major competitors currently dominate the industry.
Bone Wax Market: The global bone wax market was valued at US$ 68.8 Mn in 2017 and is projected to witness a compound annual growth rate (CAGR) of more than 2.3% from 2018 to 2026, to surpass the value of US$ 84.2 Mn by 2026.
Gene Delivery System Market: The global gene delivery system market was valued approximately US$ 2,227.8 Mn in 2016 and is anticipated to expand at a CAGR of over 7.8% from 2017 to 2025 to reach value of nearly US$ 4,281.0 Mn by 2025.
Drug Delivery Systems Market: The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025.
Gold Nanoparticles Market: The global gold nanoparticles market will exhibit a CAGR of over 15% during the forecast period, 2017 to 2026.
Drug and Gene Delivery Systems Market: The increasing prevalence of chronic diseases including diabetes and cancer is influencing the demand within the global drug and gene delivery systems market in coming years.
Ocular Drug Delivery Technology Market: The global ocular drug delivery technology market is expected to expand with a CAGR of 6.8% over the forecast period from 2017 to 2025 to attain value of US$18.12 bn by the end of forecast period from US$10.2 bn in 2016.
Prostate Cancer Therapeutics Market: The global prostate cancer therapeutics market is estimated to register growth at a CAGR of 6.9% during the forecast period, from 2022 to 2031.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com